Tenet Healthcare beats by $0.12, beats on revs; guides Q1 EPS mostly below consensus, revs below consensus; guides FY18 EPS in-line, revs in-line
- Reports Q4 (Dec) earnings of $1.40 per share, excluding non-recurring items, $0.12 better thanthe Capital IQ Consensus of $1.28 and company guidance of $1.20-$1.35; revenues rose 2.4% year/year to $4.98 bln vs the $4.85 bln Capital IQ Consensus.
- "Our results for the fourth quarter were strong in each of our business segments," said Ronald A. Rittenmeyer, executive chairman and CEO. "Volume growth returned in our hospital and Ambulatory segments, cost controls were tight, and our financial results at USPI and Conifer were very strong. Our cost control program is off to a great start and, when combined with improved financial performance in the fourth quarter, we are raising our Outlook for Adjusted EBITDA and Adjusted EPS for 2018."
- Co issues guidance for Q1, sees EPS of ($0.10)-$0.05, excluding non-recurring items, vs. $0.05 Capital IQ Consensus Estimate; sees Q1 revs of $4.45-$4.65 bln vs. $4.66 bln Capital IQ Consensus Estimate.
- Co issues in-line guidancefor FY18, sees EPS of $0.73-$1.07, excluding non-recurring items, vs. $0.78 Capital IQ Consensus Estimate and up from January pre-announcement of $0.58-$0.97; sees FY18 revs of $17.9-$18.3 bln vs. $18.26 bln Capital IQ Consensus Estimate. Adjusted EBITDA expected to be $2.50-$2.60 bln, up $25 mln at the midpoint from prior guidance